Albireo announces two financing transactions to extend cash runway into beginning of 2022

Albireo announces two financing transactions to extend cash runway into the beginning of 2022.albireo pharma inc - initial draw down of $10 million on debt facility of up to $80 million with hercules capital.albireo - restructured healthcare royalty partners elobixibat royalty monetization agreement nets additional $15 million in non-dilutive capital.
ALBO Ratings Summary
ALBO Quant Ranking